Sheaff Brock Investment Advisors LLC Grows Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sheaff Brock Investment Advisors LLC grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 27,524 shares of the pharmacy operator’s stock after acquiring an additional 3,085 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $257,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Secured Retirement Advisors LLC acquired a new stake in Walgreens Boots Alliance in the fourth quarter valued at approximately $99,000. Vontobel Holding Ltd. raised its stake in Walgreens Boots Alliance by 131.2% during the fourth quarter. Vontobel Holding Ltd. now owns 321,880 shares of the pharmacy operator’s stock worth $3,003,000 after acquiring an additional 182,644 shares during the period. Ingalls & Snyder LLC lifted its holdings in shares of Walgreens Boots Alliance by 13.6% in the 4th quarter. Ingalls & Snyder LLC now owns 338,779 shares of the pharmacy operator’s stock worth $3,161,000 after purchasing an additional 40,570 shares during the last quarter. Mill Creek Capital Advisors LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter valued at $184,000. Finally, International Private Wealth Advisors LLC boosted its stake in Walgreens Boots Alliance by 14.5% during the 4th quarter. International Private Wealth Advisors LLC now owns 14,730 shares of the pharmacy operator’s stock valued at $137,000 after purchasing an additional 1,870 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.5 %

Shares of WBA opened at $9.70 on Tuesday. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $22.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm has a market capitalization of $8.38 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.26 and a beta of 0.65. The company has a 50-day simple moving average of $10.31 and a 200-day simple moving average of $9.72.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm earned $0.66 EPS. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on WBA shares. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Finally, Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.